Why Farbe Firma is the Top Manufacturer of Cerebroprotein Hydrolysate for Injection
- Maulik Sudani
- May 16
- 5 min read
Last Updated: May 16, 2026
TL;DR: Farbe Firma Pvt Ltd manufactures Cerebroprotein Hydrolysate for Injection (60 mg / 2 mL and 90 mg / 3 mL) at its WHO-GMP certified Ankleshwar, Gujarat facility, supplying neuroprotective injectable therapy to stroke, dementia, and traumatic-brain-injury markets across 30+ countries with full CTD dossier support.
Key Takeaways
Cerebroprotein Hydrolysate is a low-molecular-weight neuropeptide complex derived from porcine brain tissue, indicated for ischaemic stroke, vascular dementia, post-traumatic brain injury, and cognitive disorders.
Farbe Firma produces both clinically relevant strengths - 60 mg/2 mL and 90 mg/3 mL - under aseptic ISO Class 5 sterile filling with terminal lyophilisation where formulation permits.
Each batch is released against USP/IP-aligned specifications: assay, peptide profile by HPLC, bacterial endotoxins (LAL), sterility, and free-amino-acid composition.
CTD/ACTD dossier packs, validated 24-month stability data, and bilingual artwork are available for Latin America, CIS, Africa, the Middle East, and South-East Asia.
Introduction
Cerebroprotein Hydrolysate for Injection has become one of the most prescribed neurotrophic agents in emerging-market neurology. Used in acute ischaemic stroke recovery, vascular dementia, Alzheimer-spectrum cognitive impairment, and post-traumatic brain injury rehabilitation, the molecule is essentially a standardised mixture of low-molecular-weight peptides and free amino acids - under 10 kDa - extracted from purified porcine brain tissue and balanced to deliver consistent neurotrophic activity in a sterile, pyrogen-free injection.
Because the product is a complex biologically-derived hydrolysate rather than a single synthetic API, manufacturing quality matters enormously. Hospital procurement teams, neurology distributors, and tender buyers look for a manufacturer who can guarantee batch-to-batch peptide profile reproducibility, viral safety, endotoxin control, and a registered Drug Master File. Farbe Firma Pvt Ltd delivers all of that from a single WHO-GMP certified facility in Ankleshwar, Gujarat - and has been doing so as a trusted CDMO partner for buyers in 30+ countries.
What Makes Cerebroprotein Hydrolysate Demanding to Manufacture
Cerebroprotein Hydrolysate is not a simple synthetic injectable. The bulk active starts as porcine brain tissue, which is then enzymatically digested, ultrafiltered to retain only the <10 kDa peptide fraction, viral-inactivated through validated low-pH and heat steps, and lyophilised into a stable amorphous bulk. Each of those upstream steps must be audit-trail traceable, and the downstream injectable line must hold the resulting peptide profile intact through aseptic filtration, filling, and 24-month shelf life.
Farbe Firma's injectable line for Cerebroprotein meets every one of those requirements. Bulk API is sourced exclusively from regulator-audited DMF-supported suppliers with TSE/BSE-free certification and ICH Q5A-compatible viral-clearance validation. The reconstituted bulk is double-filtered through 0.22 um hydrophilic PES membranes, filled under unidirectional ISO Class 5 airflow into amber type-I glass ampoules or vials, and 100% inspected for particulate matter on automated visual-inspection machines. Where the formulation calls for a lyophilised presentation, Farbe Firma offers terminal freeze-drying with validated cycle parameters and residual-moisture release limits.
Strength Profile and Pack Configurations
Farbe Firma supplies Cerebroprotein Hydrolysate Injection in the two strengths that dominate hospital formularies: 60 mg / 2 mL for standard adult dosing in vascular dementia and post-stroke recovery protocols, and 90 mg / 3 mL for acute neuroprotective regimens following ischaemic stroke or traumatic brain injury. Standard pack sizes are 1 x 1's amber type-I glass ampoule in printed mono-cartons, with 5 x 1's or 10 x 1's master cartons configured for distributor logistics.
On request, the company supplies the 60 mg and 90 mg strengths as lyophilised vials with WFI diluent ampoules - a presentation preferred in tropical-climate markets because lyophilised peptides hold longer-term stability above 25 C. Cartons are printed in-house, with bilingual artwork (English plus Spanish, French, Arabic, Portuguese, or Russian) and Pharmacopoeia-specific overprints available for regulated export channels.
Looking for Cerebroprotein Hydrolysate Injection 60 mg or 90 mg? Submit a Quick Inquiry - our export team responds within 24 hours.
Cerebroprotein Hydrolysate Injection manufacturer - quality and dossier documentation
Every released batch of Cerebroprotein Hydrolysate for Injection is tested against an in-house specification that aligns with the Indian Pharmacopoeia (IP) and is supplemented with USP-compatible methods where IP is silent. The release panel covers description, identification by HPLC peptide-mapping profile, total nitrogen content, total free amino acid content, pH, particulate matter (USP <788>), bacterial endotoxins (LAL, USP <85>), sterility (USP <71>), and container-closure integrity. Reference standards and impurity markers are maintained internally and reviewed annually.
On the dossier side, Farbe Firma maintains full CTD and ACTD packs for Cerebroprotein Hydrolysate Injection, including Module 3 (Quality) with API DMF cross-references, Module 4 (Non-clinical) safety data, and Module 5 (Clinical) literature-based summaries. Country-specific Module 1 packs cover the regulatory bodies that most frequently register the product: Roszdravnadzor (Russia), Ministry of Health Uzbekistan, INVIMA Colombia, ANVISA Brazil, NAFDAC Nigeria, and the Vietnam Drug Administration. Long-term stability data is generated under ICH Zone IV-b conditions (30 C +/- 2 C / 65 % RH +/- 5 % RH) for 24 months.
Why Farbe Firma
Farbe Firma Pvt Ltd is a WHO-GMP and ISO 9001:2015 certified pharmaceutical injectable manufacturer based in Ankleshwar, Gujarat - the heart of India's pharmaceutical injectable manufacturing belt. The facility's aseptic core is built to ISO Class 5 (Grade A) under Grade B background, with validated HVAC, environmental monitoring, and a fully equipped QC laboratory for HPLC, LAL, sterility, and microbiology testing on-site.
Across its portfolio of more than 100 sterile injectable molecules, Farbe Firma exports to 30+ countries - covering Latin America, the CIS region, Africa, the Middle East, and South-East Asia. The neurology line, which includes Cerebroprotein Hydrolysate, Piracetam, Citicoline, and Cerebrolysin-class products, is one of the company's fastest-growing therapeutic verticals because of strong tender demand across Russia, the CIS, and Latin America.
Whether you are a private distributor seeking a reliable second source, a tender consolidator preparing a multi-country bid, or a hospital group requiring a long-term private-label supplier, Farbe Firma combines WHO-GMP certification, ISO Class 5 aseptic processing, complete CTD dossier support, and zero-recall export performance into a single CDMO relationship for Cerebroprotein Hydrolysate Injection.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions
Is Farbe Firma's Cerebroprotein Hydrolysate Injection WHO-GMP certified?
Yes. Cerebroprotein Hydrolysate for Injection is manufactured at Farbe Firma's WHO-GMP certified Ankleshwar facility under ISO 9001:2015 quality systems and ISO Class 5 aseptic processing.
Which strengths are available - 60 mg or 90 mg?
Both. Farbe Firma supplies Cerebroprotein Hydrolysate Injection in 60 mg / 2 mL and 90 mg / 3 mL strengths, as solution ampoules or lyophilised vials with WFI diluent, depending on the destination market's preference.
Is the bulk API TSE/BSE-free and viral-inactivated?
Yes. Cerebroprotein Hydrolysate bulk API is sourced only from regulator-audited DMF-supported suppliers with TSE/BSE-free certification and ICH Q5A-compatible viral-clearance validation, including low-pH and heat inactivation steps.
Do you provide CTD/ACTD dossiers for Cerebroprotein registration?
Yes. Complete CTD and ACTD dossiers - Modules 1 to 5 with country-specific Module 1 packs - are available for Latin America, CIS, Africa, the Middle East, and South-East Asia, supported by 24-month ICH Zone IV-b stability data.
Can Farbe Firma supply Cerebroprotein Hydrolysate Injection under our own brand?
Yes. Farbe Firma offers private-label CMO supply with bilingual artwork, in-house carton printing, brand-specific batch coding, and Pharmacopoeia overprints (IP/BP/USP) on request.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Farbe Firma Pvt Ltd - WHO-GMP Certified Sterile Injectable Manufacturer
Website: www.farbefirma.org | Email: director@farbefirma.org
Plot No. 2818, GIDC Industrial Estate, Ankleshwar, Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments